CNBC
US · 2 hrs ago
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
Do you trust CNBC?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!